Clinical Trial Update: Safety and Efficacy of PB-119 in Subjects With Type 2 Diabetes and Not Well-controlled by Metformin Monotherapy [Phase 3]

View source ↗

Summary

Phase 3 trial assessing PB-119 safety and efficacy in adults with Type 2 Diabetes not adequately controlled on metformin alone.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• PB-119 (PB-119)

Snippet

Sponsor: PegBio Co., Ltd. | Conditions: Type 2 Diabetes Mellitus (T2DM) | Phase 3 | Status: COMPLETED